| CAS No. | 1274892-31-7 |
| Molecular Formula | C7H8BrF3N2 |
| Molecular Weight | N/A |
| Category | Pharmaceutical Standards / API Standards |
| Availability | In Stock |
6-Bromo-7-methyl-5-(trifluoromethyl)-2,3-dihydro-1H-1,4-diazepine hydrobromide (C7H8BrF3N2HBr) contains a nitrile group, fluorine/bromine substitution. Halogen substitution raises its density and boiling point; these physicochemical properties determine the optimal preparation and storage of its standard solutions. Halogen substitution (F/Cl/Br/I) produces a distinctive isotope pattern in mass spectrometry, a valuable aid for qualitative confirmation.
6-Bromo-7-methyl-5-(trifluoromethyl)-2,3-dihydro-1H-1,4-diazepine hydrobromide (CAS 1274892-31-7) is a high-purity analytical reference standard with the molecular formula C7H8BrF3N2HBr and a molecular weight of 337.96 g/mol.
This reference standard is suitable for quantitative analysis on major chromatographic platforms including HPLC, GC, LC-MS/MS, and GC-MS, serving as an external calibration standard or a system suitability test reference material.
The assigned purity is verified by mass-balance and quantitative NMR (qNMR) approaches, with the expanded uncertainty reported at a 95% confidence level (k=2). Batch homogeneity and stability are independently assessed for every lot.
| Molecular Formula | C7H8BrF3N2 HBr |
| Molecular Weight | 337.96 g/mol |
| Purity | 97%+ |
| Storage | Store at 2-8°C, protect from light |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | Light-sensitive; avoid direct strong light |
| Degree of Unsaturation (DBE) | 2.0 |
| CAS Registry Year (est.) | 1990 |
| Halogen Content | F/Br-containing |
| Nitrogen Atoms | 2 |